Article ID Journal Published Year Pages File Type
6200178 Ophthalmology 2016 12 Pages PDF
Abstract
All active first-line drugs are effective compared with placebo in reducing IOP at 3 months. Bimatoprost, latanoprost, and travoprost are among the most efficacious drugs, although the within-class differences were small and may not be clinically meaningful. All factors, including adverse effects, patient preferences, and cost, should be considered in selecting a drug for a given patient.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , , , ,